Small Caps
31 Jan
dl fusion antibodies plc aim health care healthcare health care providers health care services logo 20230306
Fusion Antibodies validation project with US NIC progresses

Fusion Antibodies announced on Friday that its OptiMAL validation project with the US National Cancer Institute (NCI) was progressing as planned.

31 Jan
dl metals one plc met1 basic materials basic resources industrial metals and mining general mining aim logo 20240212 1220
Metals One completes PEA for Finland Black Schist project

Metals One announced on Friday that it has completed a preliminary economic assessment (PEA) for its Finland Black Schist Ni-Cu-Co-Zn Project, identifying the Rautavaara (R1) deposit as the key economic driver.

31 Jan
dl celadon pharmaceuticals plc aim health care healthcare pharmaceuticals and biotechnology cannabis producers logo 20221222
Celadon still seeking finance as it draws down most of facility

Celadon Pharmaceuticals reported on Friday that it has received £0. 897m of a £1m drawdown request from its committed credit facility, with the remaining £0. 1m now expected in February.

31 Jan
dl prospex energy plc aim energy oil gas and coal oil crude producers logo 20230214
Prospex reports rise in production from Selva Malvezzi

Prospex Energy reported a significant increase in production and revenue from the Selva Malvezzi production concession in Italy on Friday, with gross revenue for the fourth quarter reaching €3. 38m, a 91% rise compared to the final three months of 2023.

31 Jan
dl cohort plc aim independent technology group company investor tech digital logo
Cohort completes acquisition of Aussie firm EM Solutions

Cohort announced the completed acquisition of EM Solutions on Friday, following earlier announcements in November and January.

31 Jan
dl faron pharma aim pharmaceuticals drugs medicine medical research and development logo
Faron identifies final patient in BEXMAB phase two study

Faron Pharmaceuticals announced on Friday that it has identified the final patient for its BEXMAB phase two dose optimisation study in refractory or relapsed myelodysplastic syndrome (r/r MDS) and its phase one and two study in frontline high-risk (HR) MDS.

31 Jan
dl reabold resources plc rbd energy energy oil gas and coal oil crude producers aim logo 20230912 1226
Reabold ups stake in West Newton gas development field

Reabold Resources announced on Friday that it has completed the acquisition of additional shares in Rathlin Energy UK from Connaught Oil & Gas for £0. 7m, increasing its equity interest in Rathlin to about 79. 8%.

31 Jan
dl gemfields group aim diamond gemstones mining production investments faberge logo
Gemfields reports progress in disrupted fourth quarter

Gemfields reported total auction revenue of $196m for 2024 on Friday, as it continued to invest in the expansion of its Montepuez Ruby Mine (MRM) in Mozambique.

31 Jan
dl focusrite aim audio music recording podcast hardware technology equipment logo
Focusrite trading as expected amid stocking headwinds

Focusrite said in an update on Friday that trading for the first half of its financial year was expected to align with the board’s expectations, with performance anticipated to be weighted towards the second half as channel destocking in the US eased.

31 Jan
dl alliance pharma plc aim health care healthcare pharmaceuticals and biotechnology pharmaceuticals logo 20230112
Alliance Pharma FY profits seen in line with expectations

International healthcare firm Alliance Pharma said on Friday that FY24 group profits would be in line with expectations despite a modest downturn in revenues.

31 Jan
dl avon protection rubber products armour armor manufacturer producer logo
Avon Technologies trades in line during Q1

Defence products manufacturer Avon Technologies said on Friday that Q1 trading was in line with expectations and that its outlook for the FY remained consistent with previous guidance.

30 Jan
dl property franchise group the tpfg real estate real estate real estate investment and services real estate services aim logo 20240807 1244
The Property Franchise Group upbeat after 'transformational' 2024

The Property Franchise Group reported a transformational 2024 on Thursday, with revenue rising 146% to £67. 2m, driven by organic growth and the acquisitions of Belvoir Group and GPEA.

30 Jan
dl somero enterprises aim laser concrete screeding technology non residential construction building logo
Somero Enterprises ends year in line with guidance

Concrete slab measurement and installation equipment specialist Somero Enterprises reported 2024 full-year revenue of $109. 2m in an update on Thursday, in line with guidance and market expectations.

30 Jan
dl fintel plc fntl industrials industrial goods and services industrial support services professional business support services aim logo 20230919 1400
Fintel flags strong full year financial, strategic performance

Fintel reported a strong full-year financial and strategic performance in an update on Thursday, with revenue increasing 21% to £78. 3m, driven by organic growth and acquisitions.

30 Jan
dl maxcyte inc aim health care healthcare pharmaceuticals and biotechnology logo 20230307
MaxCyte announces acquisition of SeQure Dx

MaxCyte announced on Thursday that it has acquired SeQure Dx, a specialist in on-target and off-target editing assessment services for cell and gene therapies, in a move aimed at broadening its offerings in the cell engineering space.

30 Jan
dl mulberry fashion luxury brand label 3
Mulberry to 'celebrate' Britishness in turnaround plan

Mulberry Group laid out turnaround plans on Thursday, including halting losses and reclaiming its position as a must-have, iconic British brand.

30 Jan
dl next fifteen communications group aim next 15 logo
Next15 FY profits seen at bottom end of market expectations

Marketing business Next 15 warned on Thursday that profits for the twelve months ending 31 January would be at the bottom end of expectations despite "an encouraging uptick" in new business wins in the latter half of the year.

30 Jan
dl novacyt group aim clinical diagnostics testing coronavirus covid 19 pcr rapid laboratory lab logo
Novacyt flags strong full-year revenue growth

Novacyt reported strong revenue growth for 2024 in an update on Thursday, with unaudited statutory revenue reaching about £19. 6m, an 85% increase from the prior year's £10. 6m.

30 Jan
dl tullow oil energy oil and gas exploration development production logo
Tullow Oil considers non-core asset sale to reduce debt pile

Oil and gas exploration firm Tullow Oil said on Thursday that it was exploring a potential sale of its non-core assets as part of an effort to bring its debt below $1. 0bn.

30 Jan
dl treatt plc food ingredients maker manufacturer beverage flavours producer logo
Treatt Q1 revenues in line with expectations, Q2 starts 'well'

Natural extracts and ingredients business Treatt said on Thursday that Q1 revenues were in line with internal expectations and that Q2 had "started well".